N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial.
McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Sinclair B, Reid D, Baker AL, Manning V, Pas NT, Thomas T, Bathish R, Raftery DK, Wrobel A, Saunders L, Arunogiri S, Cordaro F, Hill H, Hall S, Clare PJ, Mohebbi M, Berk M.
McKetin R, et al. Among authors: mohebbi m.
EClinicalMedicine. 2021 Jul 13;38:101005. doi: 10.1016/j.eclinm.2021.101005. eCollection 2021 Aug.
EClinicalMedicine. 2021.
PMID: 34308314
Free PMC article.
BACKGROUND: Methamphetamine dependence is a significant global health concern for which there are no approved medications. The cysteine prodrug, N-acetylcysteine (NAC), has been found to ameliorate glutamate dysregulation in addiction, and to reduce craving for methampheta …
BACKGROUND: Methamphetamine dependence is a significant global health concern for which there are no approved medications. The cysteine prod …